Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.47B
Market cap12.47B
Price-Earnings ratio
72.99
Price-Earnings ratio72.99
Dividend yield
Dividend yield
Average volume
409.99K
Average volume409.99K
High today
$317.24
High today$317.24
Low today
$315.89
Low today$315.89
Open price
$316.40
Open price$316.40
Volume
646.35K
Volume646.35K
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

With a market cap of 12.47B, Penumbra(PEN) trades at $317.20. The stock has a price-to-earnings ratio of 72.99.

On 2026-06-21, Penumbra(PEN) stock moved within a range of $315.89 to $317.24. With shares now at $317.20, the stock is trading +0.4% above its intraday low and -0.0% below the session's peak.

Trading activity shows a volume of 646.35K, compared to an average daily volume of 409.99K.

The stock's 52-week range extends from a low of $221.26 to a high of $362.41.

The stock's 52-week range extends from a low of $221.26 to a high of $362.41.

PEN News

Simply Wall St 2d
Penumbra Stock Could Be 12.7% Undervalued On STORM PE Trial Hopes

Penumbra (PEN) is back in focus after recent trading left the stock around $317.20, prompting investors to reassess its performance over the past month and past...

Penumbra Stock Could Be 12.7% Undervalued On STORM PE Trial Hopes
Nasdaq 4d
ClearPoint Neuro Surges 26.0%: Is This an Indication of Further Gains?

ClearPoint Neuro, Inc. CLPT shares rallied 26% in the last trading session to close at $16.81. This move can be attributable to notable volume with a higher num...

ClearPoint Neuro Surges 26.0%: Is This an Indication of Further Gains?
Investing.com 6d
Penumbra secures CE Mark for stroke treatment device in Europe - Investing.com

...

Penumbra secures CE Mark for stroke treatment device in Europe - Investing.com

Analyst ratings

91%

of 11 ratings
Buy
9.1%
Hold
90.9%
Sell
0%

More PEN News

TipRanks 6d
Penumbra secured CE Mark in Europe for Thunderbolt

Penumbra (PEN) announced it has secured CE Mark in Europe for Thunderbolt, further laying the groundwork for launching computer assisted vacuum thrombectomy tec...

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.